Follow us

Grant is a corporate lawyer who specialises in the insurance sector.

Grant works on M&A and other corporate transactions (including Part VII transfers), and has extensive experience of large and complex (re)insurance transactions. He also has an in-depth knowledge of the regulatory regime that applies to (re)insurers and (re)insurance brokers. In addition, he is a member of the firm's fintech group, and has worked companies looking to develop businesses in that sector.

Grant is recommended for non-contentious insurance work in both Chambers and Legal 500. Clients describe him as "commercial, available and flexible", as well as "very calm, analytical and supportive", and say that "the quality of his advice is superb". He is qualified as a Chartered Tax Advisor (non-practising) with the Irish Tax Institute, and is an affiliate member of the Society of Actuaries in Ireland.


Prior to joining Herbert Smith Freehills, Grant worked with a leading Irish law firm. Prior to that, he was an in-house lawyer working in the European headquarters of a leading American financial institution.

Experience & expertise

Selected matters

  • Canada Life in respect of a longevity swap covering approximately £1.4bn of pension liabilities in UBS's defined-benefit pension scheme in the UK
  • ReAssure on the Part VII transfer of the Mature Savings Business from Legal & General, which transferred approximately £30bn of assets and over 900,000 policies
  • BHP Billiton on the sale of The World Marine & General Insurance PLC to Randall & Quilter
  • Credit Suisse on a reinsurance transactions covering multi-billion pound liabilities deriving from variable-annuity and other investment-linked insurance products in the Japanese market
  • Canada Life the issuance of two longevity swaps in respect of the British Airways pension scheme, and on the subsequent restructuring of one of those longevity swaps to facilitate Legal & General's £4.4bn buy-in for the same scheme
  • many insurers and insurance brokers on restructuring their businesses in response to Brexit and related regulatory issues
  • a range of confidential prudential regulatory issues arising under Solvency II, IDD, FSMA, ancillary regulations and regulatory guidance.